Quintiles offers a range of genomic services to support oncology clinical development by identifying markers for drug efficacy, toxicity and responsiveness in a comprehensive and personalized fashion. Genomic services fully integrate into Quintiles Central Laboratory and clinical trial solutions throughout the drug development lifecycle.